• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子 VII 的凝血活性与中年男性血浆中大脂蛋白颗粒的浓度密切相关。

Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

作者信息

Mitropoulos K A, Miller G J, Reeves B E, Wilkes H C, Cruickshank J K

机构信息

MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex, U.K.

出版信息

Atherosclerosis. 1989 Apr;76(2-3):203-8. doi: 10.1016/0021-9150(89)90104-4.

DOI:10.1016/0021-9150(89)90104-4
PMID:2730717
Abstract

A community survey of factor VII coagulant activity (VIIc) and the lipoprotein profile in non-fasting plasma of middle-aged men in NW London was undertaken to search for the determinants of VIIc in the general community. The data demonstrates that associations between VIIc and the plasma concentrations of cholesterol and of triglycerides previously shown in the general population can be explained by the strong and positive associations between VIIc and the large lipoprotein particles, chylomicrons, VLDL and IDL. Consistent with the possibility that the concentration of large lipoproteins determines the in vivo reactivity of factor VII, the association between VIIc and the ratio of lipid in the d greater than 1.019 fraction to the total plasma lipid was also highly significant but negative. The observed correlations between VIIc and lipoproteins smaller than VLDL may be the product of the interrelations that exist between the lipoprotein fractions in plasma. However, the associations between VIIc and the chylomicron lipid concentrations are especially strong when allowance is made for the considerable bias towards zero in the observed correlation, due to large within-person variance in chylomicron concentration.

摘要

对伦敦西北部中年男性非空腹血浆中的凝血因子 VII 凝血活性(VIIc)和脂蛋白谱进行了一项社区调查,以寻找普通社区中 VIIc 的决定因素。数据表明,先前在普通人群中显示的 VIIc 与血浆胆固醇和甘油三酯浓度之间的关联,可以通过 VIIc 与大脂蛋白颗粒、乳糜微粒、极低密度脂蛋白(VLDL)和中间密度脂蛋白(IDL)之间强烈的正相关来解释。与大脂蛋白浓度决定因子 VII 体内反应性的可能性一致,VIIc 与密度大于 1.019 部分的脂质与总血浆脂质的比率之间的关联也非常显著,但呈负相关。观察到的 VIIc 与小于 VLDL 的脂蛋白之间的相关性可能是血浆中脂蛋白组分之间存在的相互关系的产物。然而,当考虑到由于乳糜微粒浓度的个体内差异较大,观察到的相关性存在相当大的向零偏差时,VIIc 与乳糜微粒脂质浓度之间的关联尤其强烈。

相似文献

1
Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.凝血因子 VII 的凝血活性与中年男性血浆中大脂蛋白颗粒的浓度密切相关。
Atherosclerosis. 1989 Apr;76(2-3):203-8. doi: 10.1016/0021-9150(89)90104-4.
2
The effects of intravenous Triton WR-1339 on factor VII coagulant activity and plasma lipoproteins in normocholesterolaemic and hypercholesterolaemic rabbits.静脉注射曲通WR-1339对正常胆固醇血症和高胆固醇血症兔的凝血因子VII活性及血浆脂蛋白的影响。
Blood Coagul Fibrinolysis. 1994 Aug;5(4):583-91.
3
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Arterioscler Thromb Vasc Biol. 1995 May;15(5):655-64. doi: 10.1161/01.atv.15.5.655.
4
A diet rich in high-oleic-acid sunflower oil favorably alters low-density lipoprotein cholesterol, triglycerides, and factor VII coagulant activity.富含高油酸葵花籽油的饮食能有益地改变低密度脂蛋白胆固醇、甘油三酯和凝血因子 VII 的凝血活性。
J Am Diet Assoc. 2005 Jul;105(7):1071-9. doi: 10.1016/j.jada.2005.04.008.
5
Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.慢性肾病及透析中的凝血因子VII促凝活性(VIIc)与高凝状态:与血脂异常、炎症及凝血因子VII基因型的关系
Nephrol Dial Transplant. 1998 Mar;13(3):679-84. doi: 10.1093/ndt/13.3.679.
6
The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins.在富含甘油三酯的大脂蛋白界面上,带电的长链饱和脂肪酸对枸橼酸盐血浆中因子VII的激活作用。
Blood Coagul Fibrinolysis. 1993 Dec;4(6):943-51.
7
Association between coagulation factors VII and X with triglyceride rich lipoproteins.凝血因子VII和X与富含甘油三酯的脂蛋白之间的关联。
J Clin Pathol. 1988 Sep;41(9):940-4. doi: 10.1136/jcp.41.9.940.
8
Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency.富含甘油三酯的脂蛋白的脂解作用激活凝血因子XII:一项关于家族性脂蛋白脂肪酶缺乏症的研究。
Atherosclerosis. 1992 Aug;95(2-3):119-25. doi: 10.1016/0021-9150(92)90015-9.
9
Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration.
Arterioscler Thromb. 1994 Feb;14(2):214-22. doi: 10.1161/01.atv.14.2.214.
10
Plasma lipoproteins enhance tissue factor-independent factor VII activation.血浆脂蛋白增强组织因子非依赖性因子VII的活化。
Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1835-41. doi: 10.1161/01.atv.20.7.1835.

引用本文的文献

1
Association of lifestyle-related factors with circadian onset patterns of acute myocardial infarction: a prospective observational study in Japan.生活方式相关因素与急性心肌梗死昼夜发病模式的关联:日本一项前瞻性观察研究
BMJ Open. 2014 Jun 6;4(6):e005067. doi: 10.1136/bmjopen-2014-005067.
2
The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance.代谢综合征中的血栓形成倾向:聚焦于止血和纤溶平衡受损所涉及的潜在机制。
Scientifica (Cairo). 2012;2012:525374. doi: 10.6064/2012/525374. Epub 2012 Aug 30.
3
Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.
载脂蛋白 CIII 水平升高的患者和因子 II 20210A 等位基因携带者的因子 II 活性也相似增加。
J Am Heart Assoc. 2013 Nov 15;2(6):e000440. doi: 10.1161/JAHA.113.000440.
4
A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium.以基因为中心的欧洲裔和非裔美国人凝血因子 VII 水平的关联研究:候选基因关联资源 (CARe) 联盟。
Hum Mol Genet. 2011 Sep 1;20(17):3525-34. doi: 10.1093/hmg/ddr264. Epub 2011 Jun 15.
5
Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.
Int J Hematol. 2002 Oct;76(3):279-83. doi: 10.1007/BF02982799.
6
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.苯扎贝特。其药理学及在血脂异常管理中的应用的最新进展。
Drugs. 1996 Nov;52(5):725-53. doi: 10.2165/00003495-199652050-00008.